The table below shows KalVista Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
$50.00M
-
-
-
$12.69M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$71.71M
$86.17M
$80.28M
$70.17M
$41.29M
$40.19M
SG&A
$116.29M
KALV annual revenue (10-K history)
KalVista Pharmaceuticals, Inc. reported annual revenue of $50.00M for fiscal year 2024. That is up 294.0% from $12.69M in fiscal 2020. Over the 6 fiscal years shown, annual revenue grew from $2.13M (FY 2016) to $50.00M. Figures come from the company's audited annual reports as filed with the SEC.